
Bepogen1.5%
General Pharmaceuticals Ltd.
Bepotastine Besilate ophthalmic solution is an FDA-approved topical antihistamine used for the treatment of ocular itching associated with allergic conjunctivitis.
Bepotastine Besilate ophthalmic solution is an FDA-approved topical antihistamine used for the treatment of ocular itching associated with allergic conjunctivitis.
Bepotastine Besilate should only be used for the indication and dosage form prescribed by a physician.
| Population | Dose |
|---|---|
| Adults and children ≥ 2 years | Instill 1 drop of Bepotastine Besilate into the affected eye(s) twice daily |
| Children < 2 years | Safety and efficacy not established; not recommended |
Where an oral formulation of Bepotastine Besilate is approved and marketed, the typical adult dose used is 10 mg taken twice daily; this is not an FDA-approved use and dosing should strictly follow the prescribing physician's instructions and local labeling.
No dedicated dose adjustment has been established for the ophthalmic solution given its minimal systemic absorption. For any systemic (oral) use, dose adjustment in renal or hepatic impairment should be individualized by the prescribing physician, as specific adjustment data are limited.
Most side effects of Bepotastine Besilate ophthalmic solution are mild and localized to the eye or mouth.
Patients should seek medical attention if signs of an allergic reaction occur (see Contraindications).
Bepotastine Besilate is contraindicated in patients with known hypersensitivity to bepotastine besilate or to any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.